Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist 2 mg/1 mL due to a label mix-up. The recall centres on
The US Department of Justice cited a fabricated court case in federal proceedings to oppose an immigration detainee’s bid for release from custody. The case involved petitioner Izzeddin Ahmed Abdulghaffar Daghra, who
More
ASML, the semiconductor manufacturing equipment specialist, has cemented its position as Europe’s most valuable company, boasting a market capitalisation of around €600bn (£510bn). That figure dwarfs every company listed in the UK’s
More
A sharp and sudden stock market selloff rattled investors, driven by a combination of a massive margin call and what traders described as “push-button liquidity” exiting the market. Margin calls occur when
More
The Financial Conduct Authority’s new short-selling disclosure system has drawn scrutiny after apparent errors were identified in its first batch of published data. The Financial Times first reported that the regulator’s new
More
Kelun has announced that its phase 3 OptiTROP-Lung06 study successfully met its primary endpoint in a significant win for its antibody-drug conjugate pipeline. The Chinese trial evaluated sac-TMT in combination with Merck’s
More
On 14 July 2026, the Federal Trade Commission announced a settlement with Caremark Rx, LLC and Zinc Health Services, LLC to resolve claims tied to a 2024 complaint. That complaint alleged Caremark,
More
The Department of Justice has issued third-party subpoenas targeting nine major law firms that previously reached settlements with the Trump administration over executive order disputes. The subpoenas demand communications between those firms
More
Caterpillar (NYSE: CAT) has become one of the most dominant components of the Dow Jones Industrial Average, now accounting for roughly 11% of the price-weighted index. The sheer weight of CAT within
More
The FTSE 250 index continues to attract income-focused investors searching for high-yield opportunities amid an uncertain economic climate in the UK. A dividend yield of 10% is considered exceptionally high by most
More
Veradermics has released topline results from a phase 2 study of its lead drug VDPHL01, an extended-release oral formulation of minoxidil, in women with pattern hair loss. The New Haven, Connecticut-based biotech’s
More